Glaucoma is one of the main causes of blindness throughout the world. It is characterized by death of the retinal ganglion cells, which is associated with loss of the axons making up the optic nerve. Recent studies have demonstrated support for the classification of glaucoma as a degenerative disease of the central nervous system (CNS), leading researchers to look at identifying neuroprotection strategies for the treatment of this disease, like those used for other degenerative diseases of the CNS. This book will provide an in-depth examination of the most recent findings regarding glaucoma, including risk factors, diagnosis, clinical monitoring, treatment, and above all, the need for treatment based on the concept of neuroprotection. A large part of the book is devoted to research related to this new approach to the treatment of glaucoma. * Describes the most recent developments on neuroprotection of the optic nerve, including experimental models now used and clinical protocols * Discusses new strategies for the prevention of neuronal injury in glaucoma patients * Focuses on evidence-based risk factors, innovative diagnostic aspects and advanced medical/surgical treatment of glaucomaD.K. Heuer, Department of Ophthalmology, Medical College of Wisconsin Milwaukee; Froedtert aamp; Medical College of Wisconsin, Eye ... USA T.V. Johnson, Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, UK P.T. Khaw, The School of Pharmacy, ... University of Montreal, Montreal, Canada; Department of Opthamology and Visual Sciences, University of Wisconsion, Madison, USAanbsp;...
|Title||:||GLAUCOMA: AN OPEN-WINDOW TO NEURODEGENERATION AND NEUROPROTECTION|
|Author||:||Carlo Nucci, Luciano Cerulli, Neville N. Osborne, Giacinto Bagetta|
|Publisher||:||Newnes - 2008-11-05|